How Natures NATR pricing offsets input costs Q1 2026 Profit Exceeds Views MOLN Molecular loss narrows 32 vs estimates shares unmoved as pipeline progress awaits FDA decision What Option OPCH disclosed about crisis preparedness Q1 2026 EPS Exceeds Expectations TMCI Treace Medical Concepts Inc notches narrow Q4 2025 EPS beat shares rise 374 percent on positive investor sentiment COTY Q1 2026 Earnings EPS Misses Estimates by Wide Margin Revenue Data Unavailable USAS Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Negative Surprise IMXI Q1 2026 Earnings EPS Misses Estimates Sharply as Operational Headwinds Emerge GIL Q1 2026 Earnings EPS Beats Estimates with 734 Surprise OKLO Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Advanced Nuclear Development LifeMD LFMD Rebounds 75 on Improved Volume Testing Resistance at 479 MidCap Financial Investment Notes MFICL Edges Higher 2682 Resistance in Focus Tootsie Roll Industries TR Holds Steady Near Support as Volume Remains Subdued Pulsenmore PLSM Surges 12 as Share Price Tests Key Resistance Level US Energy Corp USEG Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally